Isolation of exosomes from cultured cells and their effect in various cell culture studies have been studied by researchers to find applications in disease. Exosomes are implicated in multiple conditions, including cancer, heart failure, liver disease, and neurodegenerative disease.

Various advantages of exosomes in drug delivery, such as low toxicity, and biological barrier permeability, have fueled market growth. Potential applications in therapeutics, diagnostics, and vaccine development are further expected to fruitful the demand for Exosomes market growth in coming years.

The report “Exosomes Market, By Product (Instruments, Kits & Reagents, Services), By Workflow (Downstream Analysis, Isolation Methods), By Application (Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others), By End-Users (Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In June 2020, Sarepta deal with Codiak Biosciences to develop engineered exosomes which can deliver RNA-based treatments and gene therapy. Codiak will reel around $72.5 million under two years of deal with Sarepta.

Analyst View:

Technological advancement in analytical procedure and exosome isolation will likely propel market growth. Progress in the process for the isolation of exosomes has further facilitated the demand for Exosomes market growth over the forecast period.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Exosomes Market, By Product (Instruments, Kits & Reagents, Services), By Workflow (Downstream Analysis, Isolation Methods), By Application (Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others), By End-Users (Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Exosomes Market accounted for US$ 191.1 Million in 2024 and is estimated to be US$ 3328.2 Million by 2034 and is anticipated to register a CAGR of 4.40%. The Exosomes Market is segmented based on Product, Workflow, Application, End-Users and Region.

• Based on Product, Exosomes Market is segmented into Instruments, Kits & Reagents, Services.
• Based on Workflow, Exosomes Market is segmented into Downstream Analysis, Isolation Methods.
• Based on Application, Exosomes Market is segmented into Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others.
• Based on End-Users, Exosomes Market is segmented into Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others.
• By Region, the Exosomes Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Exosomes Market:

The prominent players operating in the Exosomes Market includes, Hologic Inc., Bio-Techne Corp., Danaher Corp., Lonza, Fujifilm Holdings Corp., Thermo Fisher Scientific Inc., QIAGEN, RoosterBio Inc., Miltenyi Biotec, Abcam plc., and others.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com